StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CBUT.JK$595.00-1.65%
Fair $595.00+0.0%

CBUT.JK

PT Citra Borneo Utama Tbk

Consumer Defensive / Packaged FoodsJakarta

$595.00

-10.00 (-1.65%)

Fairly Valued+0.0%Fair Value $595.00Fund rank 20/100 · Data gapFallback financials|
SA 32/D
F-Score: 6/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 14%

FCF escenarios

weak_data · normalized FCF $-120.3B · quality 25.7/100

Data gap 20/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 12/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

32/100

D

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · CBUT.JKLocal privado en este navegador · PT Citra Borneo Utama Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.86T

P/E

16.8x

↑

EV/EBITDA

11.7x

↑

ROE

9.6%

↑

Gross Margin

14.2%

↓

Debt/Equity

1.89

↑
52-Week Range$595
$525$2300

TradingView lightweight chart

CBUT.JK price, volumen y niveles de valoración

Último $595.00Periodo -30.8%
Fair value: $595.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+13.2%

FCF CAGR

-45.5%

FCF margin

0.9%

FCF / Net income

1.14x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $13.97T · net income $106.17B · FCF $120.69B

2022-FY → 2025-FY

Gross margin

14.2%-1.3% pts

Operating margin

2.6%-1.7% pts

Net margin

0.8%-1.6% pts

FCF margin

0.9%-6.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$13970.81B$13970.81B$9766.11B$10319.44B$9619.27B
Net Income$106.17B$106.17B$68.19B$144.24B$223.15B
EBITDA$314.07B$314.07B$226.56B$292.70B$362.29B
EPS33.9833.9821.8246.1685.70
Gross Margin14.2%14.2%11.0%12.7%15.5%
Operating Margin2.6%2.6%1.0%3.0%4.3%
Net Margin0.8%0.8%0.7%1.4%2.3%
Balance Sheet
Debt/Equity1.891.892.803.311.61
Current Ratio1.231.23———
Cash Flow
Free Cash Flow$120.69B$120.69B$-120.31B$-481.14B$747.56B
Returns
ROE9.6%9.6%7.0%16.0%29.0%
Valuation
P/E16.7616.7646.5238.1322.58
EV/EBITDA11.6811.6824.9527.9614.96
P/B1.671.673.276.096.55
Growth & Yield
Revenue Growth43.1%43.1%-5.4%7.3%—
EPS Growth55.7%55.7%-52.7%-46.1%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

15.8%

exigente

EPS terminal req.

$52.80

Spread vs growth

39.9%

5Y implied EPS CAGR

13.5%

razonable

EPS terminal req.

$63.88

Spread vs growth

42.3%

10Y implied EPS CAGR

11.7%

razonable

EPS terminal req.

$102.89

Spread vs growth

44.0%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -44.1%

Total return

-44.1%

Start / end P/E

48.8x → 17.5x

EPS bridge

21.82 → 33.98

Residual

-35.7%

EPS growth+55.7%
Multiple rerating-64.1%
Dividend+0.0%
Residual / FX / buybacks / cross-term-35.7%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.